(MedPage Today) — Apollo transcranial magnetic stimulation therapy devices were cleared by the FDA for use in adolescents with major depressive disorder (MDD), neurocare group announced.
Some parents have been trying ketamine therapy for their…
Source link : https://www.medpagetoday.com/psychiatry/generalpsychiatry/117398
Author :
Publish date : 2025-09-10 17:32:00
Copyright for syndicated content belongs to the linked Source.
